Zhejiang Hisoar Pharmaceutical Co Ltd 2024 Sustainability Report
Company: Zhejiang Hisoar Pharmaceutical Co Ltd
Sector: Manufacturing
Country: China
Year: 2024
Type: Sustainability Report
Pages: 45
The report presents the company's 2024 ESG performance across governance, environmental protection, industry value, employee rights, and social responsibility. It reports operating revenue of 193,846.57万元 and environmental protection investment of 14,346.08万元. Social responsibility highlights include 39.8万元 in external donations and public-welfare projects.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.